Registered Kenya · PPB

FASTUM GEL

KETOPROFEN

5199 2.5% G/G NEW/INNOVATOR musculo-skeletal system INN generic

What it does

Ketoprofen is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and reduce inflammation.

Commonly used for: pain relief (analgesia), inflammation reduction, arthritis (rheumatoid arthritis, osteoarthritis), muscle pain …

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
5199
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
KETOPROFEN
Dosage form
2.5% G/G
Strength
-
Pack size
N/A
Therapeutic class
NEW/INNOVATOR
ATC class (WHO)
M01AE - Propionic acid derivatives
RxNorm RxCUI
6142
Manufacturer / MAH
Phillips Therapeutics
Country of origin
FOREIGN
Manufacturer location
Embakasi South, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 22:09:38 · updated 2026-03-12 04:53:00

Drug Interactions

14
Check interactions

Pharmacodynamic Warnings

Ketoprofen appears in TABLE 2: Drugs that cause nephrotoxicity

Ketoprofen appears in TABLE 4: Drugs with antiplatelet effects

Ketoprofen appears in TABLE 16: Drugs that increase serum potassium

Ketoprofen appears in TABLE 18: Drugs that cause hyponatraemia

Severe (1)

Mifamurtide - decreases efficacy

NSAIDs(high-dose)arepredictedtodecreasetheefficacyof mifamurtide.Avoid.rTheoretical

Severe Theoretical

Moderate (5)

Antiarrhythmics - increases exposure

NSAIDs (celecoxib) are predicted to increase the exposure to antiarrhythmics (flecainide, propafenone). Monitor and adjust dose.

Moderate Theoretical

Cladribine - increases exposure

NSAIDs(sulindac)mightincreasetheexposuretocladribine. Avoidoradjustdose.oTheoretical

Moderate Theoretical

Flecainide - increases exposure

NSAIDs (celecoxib) are predicted to increase the exposure to antiarrhythmics (flecainide, propafenone). Monitor and adjust dose.

Moderate Theoretical

Pemetrexed - increases exposure

NSAIDs are predicted to increase the exposure to pemetrexed. Use with caution or avoid. Also see TABLE 2 p. 1517

Moderate Theoretical

Propafenone - increases exposure

NSAIDs (celecoxib) are predicted to increase the exposure to antiarrhythmics (flecainide, propafenone). Monitor and adjust dose.

Moderate Theoretical

Unknown (8)

Alendronate - increases risk of gastrointestinal irritation

NSAIDs are predicted to increase the risk of gastrointestinal irritation when given with bisphosphonates (alendronate, ibandronate).

Unknown Study

Bisphosphonates - increases risk of gastrointestinal irritation

NSAIDs are predicted to increase the risk of gastrointestinal irritation when given with bisphosphonates (alendronate, ibandronate).

Unknown Study

Bisphosphonates - increases risk of renal impairment

NSAIDs are predicted to increase the risk of renal impairment when given with bisphosphonates (clodronate).

Unknown Study

Clodronate - increases risk of renal impairment

NSAIDs are predicted to increase the risk of renal impairment when given with clodronate.

Unknown Study

Deferasirox - increases risk of gastrointestinal bleeding

NSAIDs are predicted to increase the risk of gastrointestinal bleeding when given with deferasirox.

Unknown Theoretical

Deferiprone - increases exposure

NSAIDs(diclofenac)arepredictedtoincreasetheexposureto deferiprone.oTheoretical

Unknown Theoretical

Ibandronate - increases risk of gastrointestinal irritation

NSAIDs are predicted to increase the risk of gastrointestinal irritation when given with bisphosphonates (alendronate, ibandronate).

Unknown Study

Ironchelators - increases risk of gastrointestinal bleeding

NSAIDs are predicted to increase the risk of gastrointestinal bleeding when given with iron chelators (deferasirox).

Unknown Theoretical

Data from BNF 85 (British National Formulary). This is not a substitute for professional medical advice. Matched via: class

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Ketoprofen is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and reduce inflammation.

What it treats

  • pain relief (analgesia)
  • inflammation reduction
  • arthritis (rheumatoid arthritis, osteoarthritis)
  • muscle pain
  • menstrual pain
  • gout

How it works

Ketoprofen works by blocking certain chemicals in the body that cause pain and inflammation.

Who it's for

Ketoprofen is for adults who need relief from pain or inflammation.

Drug class

NSAIDs

Cautions

  • • Avoid using with other drugs that can harm the kidneys.
  • • Be cautious if taking medications that affect blood clotting.
  • • Use with care if on medicines that can raise potassium levels.
  • • Monitor if using drugs that can lower sodium levels.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: Ketoprofen

BNF-referenced

Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that exhibits analgesic, anti-inflammatory, and antipyretic properties. It is commonly used to relieve pain and inflammation associated with musculoskeletal disorders such as rheumatoid arthritis and osteoarthritis, as well as to alleviate moderate pain from various causes. Due to its mechanism of action and pharmacological profile, ketoprofen is effective in managing conditions that involve pain and inflammation.

Indications

  • Pain and inflammation in musculoskeletal disorders
  • Rheumatoid arthritis
  • Osteoarthritis
  • Dysmenorrhea
  • Moderate pain relief

Mechanism of action

Ketoprofen's anti-inflammatory effects are primarily due to the inhibition of cyclooxygenase-2 (COX-2), an enzyme crucial for prostaglandin synthesis in the arachidonic acid pathway. This leads to reduced levels of prostaglandins, which mediate pain, fever, and inflammation. Ketoprofen also inhibits cyclooxygenase-1 (COX-1), contributing to its side effects such as gastrointestinal discomfort and ulceration. Additionally, it exhibits anti-bradykinin activity and stabilizes lysosomal membranes. Its antipyretic effects may involve action on the hypothalamus, enhancing peripheral blood flow, vasodilation, and heat dissipation.

Pharmacodynamics

As a nonsteroidal anti-inflammatory agent (NSAIA), ketoprofen shares pharmacological actions with other typical NSAIDs by inhibiting prostaglandin synthesis. It is effective in treating various conditions, including rheumatoid arthritis, osteoarthritis, and dysmenorrhea, and is used to alleviate moderate pain, thus providing both analgesic and anti-inflammatory effects.

Pharmacokinetics

Ketoprofen is absorbed from the gastrointestinal tract, with peak plasma concentrations typically reached within 1 to 2 hours after oral administration. It is extensively metabolized in the liver, primarily through conjugation, and excreted mainly via the urine. The drug has a half-life of approximately 1.5 to 2 hours, but this may vary based on individual factors such as age and liver function. Caution is advised in patients with hepatic or renal impairment, as these conditions may alter the drug's pharmacokinetics and increase the risk of adverse effects.

Contra-indications

  • History of gastrointestinal perforation or ulceration
  • Severe heart failure
  • History of hypersensitivity to aspirin or other NSAIDs

Adverse effects

  • Gastrointestinal discomfort
  • Nausea
  • Constipation
  • Dizziness
  • Drowsiness
  • Fatigue
  • Headache
  • Rash
  • Paraesthesia
  • Skin reactions
  • Increased risk of infection
  • Angioedema
  • Renal impairment
  • Hypersensitivity reactions
  • Photosensitivity
  • Hematologic disorders
  • Stomatitis
  • Tinnitus
  • Vision disorders
  • Weight increase

Interactions

  • May affect performance of skilled tasks such as driving
  • Other NSAIDs may increase the risk of adverse effects

Precautions

  • Caution in patients with dehydration or renal impairment
  • Use with caution in elderly patients due to increased risk of serious side effects
  • Careful monitoring required for prolonged therapy
  • Caution advised in patients with a history of gastrointestinal disorders

Pregnancy

Avoid unless the potential benefit outweighs the risk. Avoid during the third trimester due to risk of fetal ductus arteriosus closure.

Breast-feeding

Amount probably too small to be harmful, but use with caution and avoid large amounts.

Storage

Store at room temperature, away from moisture and heat.

Formulations

  • Oral suspension
  • Oral solution
  • Suppositories
BNF 85 (British National Formulary) p.1280 PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: Ketoprofen

PubChem CID 3825

Molecular formula: C16H14O3

Mechanism of action

The anti-inflammatory effects of ketoprofen are believed to be due to inhibition cylooxygenase-2 (COX-2), an enzyme involved in prostaglandin synthesis via the arachidonic acid pathway. This results in decreased levels of prostaglandins that mediate pain, fever and inflammation. Ketoprofen is a non-specific cyclooxygenase inhibitor and inhibition of COX-1 is thought to confer some of its side effects, such as GI upset and ulceration. Ketoprofen is thought to have anti-bradykinin activity, as well as lysosomal membrane-stabilizing action. Antipyretic effects may be due to action on the hypothalamus, resulting in an increased peripheral blood flow, vasodilation, and subsequent heat dissipation.

Pharmacodynamics

Ketoprofen is a nonsteroidal anti-inflammatory agent (NSAIA) with analgesic and antipyretic properties. Ketoprofen has pharmacologic actions similar to those of other prototypical NSAIDs, which inhibit prostaglandin synthesis. Ketoprofen is used to treat rheumatoid arthritis, osteoarthritis, dysmenorrhea, and alleviate moderate pain.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.